RE: RE: RE: SOME PEOPLEI don't see any conspiracy at all. I doubt they want the price low. This is a microcap biotech. Notoriously difficult to raise funds at the best of times. That said, I still like the drug and the test results to date. Its too bad they have taken so long to advance it. Only have to look at the history to know why this is at .105 today. Shareholders have lost faith in management as they have taken way too long to get to clinical. Now with Dr. Sokell running the program, maybe things will be different. Worth a shot at .105?
BTW, what creditors are you referring to or did you just make that up?